Objectives. The mechanism linking inflammation to atherosclerosis is unknown. We have previously demonstrated a high occurrence of inflammation in the aortic adventitia of patients with coronary artery disease (CAD), which was more pronounced in patients with inflammatory rheumatic diseases (IRDs), and which might be involved in the pathogenesis of cardiovascular disease. In theory, infections might play a role in the pathogenesis of vascular inflammation or atherosclerosis, or both. This study compared seropositivity and the burden of several common infections in patients with CAD, both with and without IRD, and in healthy controls (HCs). Moreover, we looked for relationships between the examined antibodies and inflammatory infiltrates in the aortic adventitia.
Introduction
Patients with inflammatory rheumatic diseases (IRDs) show significantly increased occurrences and morbidity of coronary artery disease (CAD) [1] . In addition to traditional risk factors, acute and chronic inflammation seems to play a major role in the development of atherosclerosis [24] . Interestingly, inflammation in atherosclerosis has similar characteristics to those found in RA [5] . Both phenomena might therefore have a common pathogenic mechanism.
The pathogenic role of infections in IRD as well as atherosclerosis has been suggested. There are indications that CMV, Chlamydophila pneumoniae, Mycoplasma pneumoniae, Helicobacter pylori and parvovirus B19 could be related to atherogenesis [69] and one of these and some others have been related to IRD, including vasculitis [parvovirus B19, group A streptococci (GAS) and hepatitis B and C] [1012] . However, these issues are far from clear.
The common features of inflammation in both disorders (i.e. IRD and CAD) could account for their pathogenic interaction [5] . Several mechanisms could promote inflammatory responses in atherosclerotic disorders, such as modified lipid molecules, HSPs and danger-associated molecular patterns. However, like in IRD, microbial antigens interacting with Toll-like receptors (TLRs) have also been suggested to promote inflammation during atherogenesis [6, 13, 14] . In fact, it is possible that the bidirectional interaction between CAD and IRD could reflect common triggers of inflammation like certain microbes. To examine a possible role of infections in the accelerated cardiovascular disease in IRD, we compared the occurrences of serological markers for several common infections in patients with CAD and IRD, in patients with CAD only, in patients with IRD without CAD and in healthy individuals.
Methods

Patients
We examined sera from two groups of patients included in the Feiring Heart Biopsy Study: 67 CAD patients with IRD (CAD-IRD group) and 52 CAD patients without IRD (CAD-non-IRD group) referred to coronary artery bypass surgery (CABG) [15] . We matched the CAD-IRD and the CAD groups at the group level for age and sex [15] . We enrolled the CAD groups consecutively at two cardiac surgery centres in Norway (the Feiring Heart Clinic, Feiring, and the University Hospital of North Norway, Tromsø) between May 2001 and June 2004 [16] . The blood tests were collected pre-operatively, and a single rheumatologist (I.H.) examined the patients to verify the rheumatologic diagnosis and to assess disease severity and activity. The diagnosis of other diseases was based on the clinical diagnosis registered in the medical records. The inclusion criteria were age >18 years and the absence of any clinically significant infection and malignancy, and in the CAD-non-IRD group, the patients were carefully checked for the absence of IRD and psoriasis. For comparison, we also included blood samples from 30 healthy controls (HCs) recruited among the staff of Lillehammer Hospital and their acquaintances. The inclusionary criteria for the HC group were age >18 years and the absence of any clinically significant disease, trauma or surgery during the preceding 6 weeks; the absence of pregnancy, alcohol and drug abuse; and the same age range as the CAD group. The Regional Ethics Committee for Medical Research (Health Region East and South Norway) approved the study, and all the patients gave their written informed consent.
Serological analyses
All assays were routinely analysed in a blinded manner at our laboratory (Sykehuset Innlandet Hospital Trust, Lillehammer) according to the manufacturer's instructions. IgG and IgM antibodies against CMV were measured by the semi-quantitative AxSYM (Abbott Laboratories, Abbott Park, IL, USA), CMV IgG and IgM Microparticle Enzyme Immunoassay (MEIA) on the Abbott AxSYM system (Abbott Laboratories, Abbott Park, IL, USA). We considered CMV IgG results to be negative with a threshold value (TV) of <6 and positive TV 56. For CMV IgM, test values were negative <0.499 s/co and positive 55 s/co. For IgG antibody avidity, we used the VIDAS CMV IgG Avidity test (bioMerieux, Marcy-l'Etoile, France) on a miniVIDAS instrument (bioMerieux). An avidity index <0.2 indicates primary infection in the past 3 months.
We employed a solid-phase EIA (ANILabsystems, Vantaa, Finland) for the detection of IgM, IgA and IgG against C. pneumoniae antibodies and M. pneumoniae antibodies, respectively. We also determined the absorbance measurement on Multiskan Plus version 1.43 (Titertek) at 450 nm.
The results for M. pneumoniae and C. pneumoniae were described as C. pneumoniae/M. pneumoniae IgM positive when s/co >1.1, C. pneumoniae/M. pneumoniae IgA positive at >12 EIU and C. pneumoniae/M. pneumoniae IgG positive at > 45 EIU.
IgM and IgG against parvovirus B19 were measured by using both parvovirus B19 IgM and IgG EIA (Biotrin, Dublin, Ireland). We determined all values with a calculated cutoff value and translated them into results in accordance with the manufacturer's instructions. For HpIgG VIDAS, H. pylori IgG (bioMerieux) on a miniVIDAS instrument (bioMerieux) was used. The TVs for negative results were <1.00, and for positive results 51.00.
We employed ASD and AST kits (bioMerieux) to examine the sample semi-quantitatively for streptococcus anti-deoxyribonuclease B (ASD) and anti-streptolysin O antibody (AST), respectively. We also assumed titre values of 200 E/ml (ASD) and >200 E/ml (AST) to be positive.
We screened all samples for HBsAg, hepatitis B surface IgG antibody (anti-HBs) together with hepatitis B core antibody (anti-HBc), and hepatitis C antibody (anti-HCV) on an Abbott Architect i2000 (Abbott Laboratories). We repeated the reactive tests twice for confirmation.
Current and previous infection and infectious burden Table 1 shows the definitions of current and previous infections. For the estimated infectious burden, we summed up patient-wise the numbers of current and previous infections, respectively. We then made a comparison on the group level.
Statistics
The demographic and clinical data are presented as means with S.D. or proportions. We calculated the chisquare and Fisher's exact test for contingency tables in order to detect associations between categorically independent variables. We employed Monte Carlo simulation when the observed number was <5. We also calculated an independent samples t-test for continuous normally distributed variables to identify differences between two groups. For possible risk factors in the multiple binary logistic analyses, we used variables with a P-value 4 0.25 in univariate analyses, which are listed in Table 2 . As our strategy was pragmatic, we calculated a multiple binary logistic regression analysis by means of a manual backward-elimination procedure. The estimation of correlation between risk factors preceded the multivariate analyses [17] . To examine the association between mycoplasma IgA and the occurrence of adventitial inflammatory cells, we performed a binary logistic regression analysis, adjusting for potential confounders known from the literature. All estimates were performed with SPSS for Windows, version 16 (SPSS Inc, Chicago, IL, USA). We set the level of statistical significance at 0.05, and all statistical tests were two-sided. 
Results
Patients' characteristics Table 2 shows the characteristics of the study populations. The CAD-IRD and CAD-non-IRD groups were of similar age, but the age of the HCs was significantly lower. CRP and ESR were significantly lower in the HC group compared with the combined CAD group, and CRP was higher in the IRD-CAD group than in the CAD-non-IRD group. The duration from angiography to CABG was shorter for the CAD-IRD patients than for the CAD-non-IRD patients ( Table 2 ). The CAD-IRD group consisted of patients with seropositive RA (n = 24), PsA (n = 10), SLE (n = 3), AS (n = 6), reactive arthritis (n = 1), GCA (n = 6), PMR (n = 15), primary SS (n = 1) and undifferentiated collagenosis (n = 1).
Serological findings Table 3 shows the occurrences of antibodies to the examined infections. The occurrence of C. pneumoniae IgA and CMV IgM antibodies in the IRD-CAD group was higher than in the CAD-non-IRD group, although not statistically significant. Apart from a lower occurrence of CMV IgG in HCs vs the combined CAD group, there were no other differences in the occurrence of the examined antibodies between the examined groups (Table 3 ). Other potential risk factors for combined CAD vs HC from the univariate analysis were age, ESR and CRP. The multivariate analysis revealed no statistically significant risk factors, and there were no statistically significant differences in the occurrence of antibodies between the groups. There were no statistically significant differences in the occurrences of the examined antibodies between patients with RA, spondyloarthritis, GCA/PMR and systemic CTDs. We did not identify any cases of active HBV infection/ carrier state in the study. With regard to anti-HCV, there were no cases in the HC group, but one reactive anti-HCV titre in the CAD-non-IRD group (Table 3) .
Estimated infectious burden
With respect to the previous infectious burden, the whole study population had antibodies against at least one of the examined infectious agents. Univariate and multivariate analyses did not reveal any significant relationships in either the current or previous infectious burden between CAD-IRD and the CAD-non-IRD group and HC group (data not shown). Only one patient had antibodies that indicated two current infections, and most individuals had no serologic signs of current infections by the examined micro-organisms.
Serological markers in relation to adventitial and epicardial cells
We finally looked for associations between the occurrence of aortic adventitial and epicardial inflammatory cell infiltrates [15, 16] and seropositivity for the examined infections. Somewhat surprisingly, M. pneumoniae IgA positivity was negatively associated with the occurrence of adventitial inflammatory cell infiltrates (OR = 0.409, 95% CI 0.172, 0.974, P = 0.043). The association remained significant after we adjusted for the potential confounding effect of age, sex, IRD, CAD and smoking (adjusted OR = 0.303, 95% CI 0.112, 0.822, P = 0.0190). We did not find any other statistically significant association between any of the other examined antibodies or infectious burden and the occurrence of aortic adventitial or epicardial mononuclear cell infiltrates.
Discussion
In this seroepidemiological study, patients with CAD had higher occurrences of IgG antibodies to CMV than patients without CAD. After adjusting for age as well as other relevant variables, we found no significant difference in antibodies against certain selected microbes between CAD patients with and without IRD and HCs. In all three groups, the occurrence of seropositivity to the examined micro-organisms was in accordance with expected rates for a healthy population without clinically apparent infections [1821] . Furthermore, the previous and current infectious burden was similar in the three groups. Therefore our results do not support the hypothesis that increased susceptibility to these infections causes CAD and accelerated CAD in IRD patients. However, relatively few patients were studied and several diagnoses were included in the IRD group, so we cannot totally rule out a role for infections in these disorders. Recent studies strongly suggest the possible role of infections in hypertension and cardiovascular disease [22] . Furthermore, CMV replication and CMV seropositivity appear to be associated with impaired endothelial dysfunction in both children and middle-aged patients [23, 24] .
Several studies have shown that DNA-form microorganisms can be detected in both bone marrow and synovial tissue from patients with IRD, and microorganisms can be found in atherosclerotic plaque in atherosclerosis [11, 2527] . In theory, a vascular infection might lead to a destabilization of atherosclerotic plaques without influencing the levels of circulating antibodies. IRD, and potentially atherosclerosis, might be associated with immunological pathologies leading to the impaired production of antibodies [28] . Serology, therefore, might not give the right picture, not even for current infection.
Prednisolone has been shown to diminish the production of antigen-specific IgM in animal models. Both prednisolone and MTX reduce the amount of natural IgM, which protects immediately after infection, before the antigen-specific IgM takes over the protection [29] . If this is valid for humans, then patients treated by prednisolone or MTX therapy will have reduced production of antigen-specific IgM, as well as a higher susceptibility to infections. For SSZ and LEF, the reduction of antigenspecific immune response has been demonstrated in humans in vivo [30, 31] . Thus autoimmune disease and immunosuppressive therapy might mask an ongoing infection: these patient groups might not necessarily be able to express an effectual antibody response to a microbial invasion. Moreover, factors like accelerated ageing of the immune system in patients with autoimmune diseases [25, 32] might lead to premature onset of CAD in IRD patients. Given that the occurrence of protective antibodies is a sign of a well-functioning immune system, the significantly higher occurrence of protective mycoplasma IgA might be a real expression of protection. However, due to a type 1 error, the negative association between M. pneumoniae IgA in CAD patients and the occurrence of adventitial inflammatory cell infiltrates might also be an accidental finding.
Therefore, further studies with different investigatory strategies are needed to illuminate the relationship between CAD, IRD and infection. There is a need for larger studies that include both blood tests and the detection of bacterial and viral antigens in vascular tissue. Furthermore, we propose that it would be useful to focus not only on the occurrence of infectious agents in vascular tissue, but also on the pathogenetic mechanisms that damage the arterial walls.
Limitations
The present study has several potential limitations. The number of patients was too small for detailed explorations of associations and subgroup analyses, thus the lack of statistical significance in some results might have actually been type 2 errors, which mask true differences. In particular, the inclusion of several diagnoses in the IRD group, some of them consisting of only one individual (e.g. reactive arthritis and SS), weaken our conclusion. Nevertheless, our sample size is still relatively large compared with other published studies of infections in IRD. Furthermore, to our knowledge, this is the only study that compares infections in rheumatic and non-rheumatic patients with CAD. Another limitation of our study is the heterogeneity of the IRD group, including various rheumatic diseases.
The number of infections focused on in this study is not complete. Many others, including both bacterial and viral agents, need further investigation. The time of incubation with the infectious agents and the latency period between infection, possible symptoms of infection and previous occurrence of antibodies against M. pneumoniae, C. pneumoniae, CMV, Streptococcus pyogenes, H. pylori, B19, HBV and HCV are unknown. In this study, no data were collected on the oral hygiene of the patients. Based on the possible role of inflammation in the oral cavity in these disorders, this lack of data is also a limitation of the study.
Even if all laboratory precautions for limiting the unspecific binding of antibodies and rheumatic factor have been taken, we cannot rule out the possibility of unspecific binding of antibodies due to other factors in the blood samples. Nor did we analyse the cross-reaction of antibodies or polyclonal activation of B cells.
Microimmune fluorescence (MIF) is commonly considered as the gold standard analysis for detection of C. pneumoniae and M. pneumoniae antibodies [33] .
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In our study, we chose commercial ELISA assays because the method is investigator independent and provides high reproducibility in contrast to in-house MIF assays. We did not match the HC group to the CAD groups because the inclusion of completely healthy older volunteers was not feasible. Nevertheless, the ages of the healthy individuals were within the age range of the CAD groups. In addition, we adjusted our analyses for age by statistical methods.
Moreover, owing to the small sample size, we were not able to look for an association between seropositivity for the examined infections and immunosuppressive treatment. Our results cannot be generalized to patients with advanced renal failure or severe multi-organ complications because these patients are not typically accepted for CABG at the Feiring Heart Clinic. In addition, the study is cross-sectional and therefore does not confirm any causeeffect relationships.
Conclusion
In conclusion, our study does not support the hypothesis that chronic infections or infectious burden contribute to accelerated occurrence of CAD in IRD. After the adjustment for age, patients with and without CAD had similar occurrences of antibodies to C. pneumoniae, M. pneumoniae, H. pylori, CMV, B19, GAS, HBV and HCV, as well as previous and current infectious burden by these micro-organisms. The seropositivity to the examined infections and infectious burden was also similar in CAD patients with and without IRD comorbidity. Mycoplasma IgA seropositivity was related to a lower occurrence of aortic adventitial inflammation. Nevertheless, our findings do not definitively rule out a role that these infections might play in CAD and IRD.
Rheumatology key messages
. Several common infections do not appear to be associated with cardiovascular disease. . Several common infections do not appear to be associated with accelerated cardiovascular disease in rheumatic patients. . Mycoplasma IgA might be negatively related to aortic adventitial inflammation.
